ÂÜÀòÂÒÂ×

Alessandra Cesano is an experienced executive in the pharmaceutical industry, currently serving as Chief Medical Officer at ESSA Pharmaceuticals since July 2019 and at NanoString Technologies, Inc. since July 2015. Previously, Cesano held the position of CMO at Cleave Biosciences from February 2014 to June 2015, and served as COO/CMO at Nodality Inc from March 2008 to January 2014. Additionally, Cesano was the VP of Oncology and VP of Clinical Development Oncology at Biogen Idec from 2006 to 2008, and worked in clinical development and regulatory affairs at Amgen, Inc. from 2000 to 2006.